Plant biotechnology's rush to market

Monsanto's shareholders have seen the value of their shares increase four-fold since 1994. Still, even faithful investors may have paused for thought as they read the explanation offered in the group's latest annual report for a 15% dividend cut.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Register for
Free Trial

  • 14 day access to subscriber-only content



Prices on request

  • Full access to for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits